Description

• Continuum RESP is a modified live intranasal vaccine containing attenuated canine adenovirus-2 (CAV-2), parainfluenza virus, and Bordetella bronchiseptica avirulent live culture

Indications

• Continuum RESP is for vaccination of healthy susceptible puppies and dogs 3 weeks of age or older for prevention of canine infectious tracheobronchitis (ITB), also known as kennel cough, due to CAV-2, parainfluenza virus, and B. bronchiseptica

Efficacy and Safety

• Protection against virulent CAV-2, parainfluenza virus, and B. bronchiseptica in 3-week-old puppies, as demonstrated in challenge studies
• Studies established 72-hour onset of immunity in the aid in the prevention of B. bronchiseptica in 8-week-old puppies
• Intranasal vaccination with Continuum RESP stimulates rapid, local immunity in the respiratory tract, thereby inhibiting infection at the port of entry as well as preventing clinical signs
• In addition to local immunity, Continuum RESP also stimulates systemic immunity within 3 weeks of intranasal administration
• Small volume (0.4 mL) and one-nostril application provide for ease in vaccination, particularly in small breeds and young puppies
• Safe in puppies as young as 2 weeks of age, as demonstrated in extensive internal and field safety studies
• Safe for pregnant bitches
• 99.9% reaction free

Directions for Use

• Aseptically administer 0.4 mL into one nostril (because of the small dose volume, an applicator tip is not required for administration)
• Healthy puppies 3 weeks of age or older and dogs should be vaccinated at least 72 hours prior to confinement or when risk of ITB may exist
• Revaccinate annually